Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
12.81
-0.40 (-3.03%)
Nov 21, 2024, 11:34 AM EST - Market open

Company Description

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally.

The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.

The company also provides microbiological and analytical chemistry testing, as well as technical assistance, regulatory consulting, and advisory services.

It serves medical devices, pharmaceuticals, food safety, agricultural products, cancer treatment, and high-performance materials industries, as well as commercial, advanced, and specialty application industries.

The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020.

Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

Sotera Health Company
Sotera Health Company logo
Country United States
Founded 2015
IPO Date Nov 20, 2020
Industry Diagnostics & Research
Sector Healthcare
Employees 3,000
CEO Michael Petras

Contact Details

Address:
9100 South Hills Boulevard, Suite 300
Broadview Heights, Ohio 44147
United States
Phone 440 262 1410
Website soterahealth.com

Stock Details

Ticker Symbol SHC
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $23.00
CIK Code 0001822479
CUSIP Number 83601L102
ISIN Number US83601L1026
Employer ID 47-3531161
SIC Code 8090

Key Executives

Name Position
Michael B. Petras Jr. Chairman and Chief Executive Officer
Jonathan M. Lyons Senior Vice President and Chief Financial Officer
Michael P. Rutz President of Sterigenics
Robert G. Hauzie Chief Information Officer
Kristin A. Gibbs Chief Marketing Officer
William O. Lehmann Jr., J.D., M.B.A. Senior Vice President of Strategy and Corporate Development
Sally R. Turner Chief Human Resources Officer
Danielle J. Menture Senior Vice President of Global Environmental, Health and Safety and Sustainability
Joseph A. Shrawder President of Nelson Labs
Riaz Amirali Bandali M.B.A. President of Nordion

Latest SEC Filings

Date Type Title
Nov 20, 2024 8-K Current Report
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 5, 2024 10-Q Quarterly Report
Nov 5, 2024 8-K Current Report
Nov 4, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Sep 13, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Sep 6, 2024 8-K Current Report
Sep 5, 2024 424B7 Filing